Diphenyleneiodonium

Diphenyleneiodonium

SCHEMBL29486373

c1ccc2c(c1)[I+]c1ccccc1-2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 16/20 1.00
▸ MEN1 O00255 3/20 1.00
▸ KMT2A Q03164 3/20 1.00
▸ CYBB P04839 2/20 1.00
▸ NOX5 Q96PH1 2/20 1.00
▸ NOX4 Q9NPH5 2/20 1.00
▸ NOX1 Q9Y5S8 2/20 1.00
▸ NPC1 O15118 2/20 1.00
▸ ALDH1A1 P00352 2/20 1.00
▸ MAPK1 P28482 2/20 1.00
▸ SMN1; SMN2 Q16637 2/20 1.00
▸ TP53 P04637 1/20 1.00
▸ CYP1A2 P05177 1/20 1.00
▸ CYP3A4 P08684 1/20 1.00
▸ CYP2D6 P10635 1/20 1.00
▸ CYP2C9 P11712 1/20 1.00
▸ TSHR P16473 1/20 1.00
▸ CYP2C19 P33261 1/20 1.00
▸ THPO P40225 1/20 1.00
▸ STAT6 P42226 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diphenyleneiodonium SCHEMBL219548 1.00 GPR3 (1.00) GPR3MEN1KMT2ACYBBNOX5
Diphenyleneiodonium SCHEMBL30150802 0.97 GPR3 (1.00) GPR3MEN1KMT2ACYBBNOX5
Diphenyleneiodonium SCHEMBL159318 0.97 GPR3 (1.00) GPR3MEN1KMT2ACYBBNOX5
Diphenyleneiodonium SCHEMBL10834144 0.97 GPR3 (0.93) GPR3MEN1KMT2ACYBBNOX5
Diphenyleneiodonium SCHEMBL5547280 0.94 GPR3 (0.94) GPR3MEN1KMT2ACYBBNOX5
Diphenyleneiodonium SCHEMBL2057393 0.84 GPR3 (0.73) GPR3MEN1KMT2ACYBBNOX5
SCHEMBL8367212 0.81 — —
Diphenyleneiodonium SCHEMBL3733575 0.80 GPR3 (0.68) GPR3MEN1KMT2ACYBBNOX5
Hydrochloric Acid SCHEMBL8168843 0.77 — —
SCHEMBL795440 0.72 GPR3 (0.54) GPR3MEN1KMT2ACYBBNOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025034879-A1 COMPOSITIONS AND METHODS FOR TARGETING CYTOCHROME P450 REDUCTASE COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2025-02-13 — — WO claimed
EP-4213901-A1 COMPOUNDS, TARGETS AND PATHWAYS FOR MACROPHAGE MODULATION Massachusetts Institute of Technology (US) 2023-07-26 — — EP claimed
WO-2022060466-A1 COMPOUNDS, TARGETS AND PATHWAYS FOR MACROPHAGE MODULATION MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2022-03-24 — — WO claimed
WO-2025034879-A1 COMPOSITIONS AND METHODS FOR TARGETING CYTOCHROME P450 REDUCTASE COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2025-02-13 — — WO disclosed
US-20220244263-A1 METHODS FOR TREATING SMALL CELL NEUROENDOCRINE AND RELATED CANCERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-08-04 — — US disclosed
Send feedback